PL449854A1 - Kompozycja farmaceutyczna, lecznicza woda pitna, ich zastosowanie i sposób wytwarzania leczniczej wody pitnej - Google Patents

Kompozycja farmaceutyczna, lecznicza woda pitna, ich zastosowanie i sposób wytwarzania leczniczej wody pitnej

Info

Publication number
PL449854A1
PL449854A1 PL449854A PL44985424A PL449854A1 PL 449854 A1 PL449854 A1 PL 449854A1 PL 449854 A PL449854 A PL 449854A PL 44985424 A PL44985424 A PL 44985424A PL 449854 A1 PL449854 A1 PL 449854A1
Authority
PL
Poland
Prior art keywords
drinking water
pharmaceutical composition
therapeutic
therapeutic drinking
producing
Prior art date
Application number
PL449854A
Other languages
English (en)
Inventor
Piotr OKONIEWSKI
Original Assignee
Okoniewski Piotr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Okoniewski Piotr filed Critical Okoniewski Piotr
Priority to PL449854A priority Critical patent/PL449854A1/pl
Priority to PCT/PL2024/050078 priority patent/WO2026063805A1/en
Publication of PL449854A1 publication Critical patent/PL449854A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/02—Acaricides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/04—Insecticides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Insects & Arthropods (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest kompozycja farmaceutyczna zawierająca co najmniej jeden związek izoksazoliny lub jego soli lub solwatu oraz farmaceutycznie dopuszczalny nośnik, podawana doustnie przez wodę pitną, zawierająca ester pochodzący z nasyconego lub nienasyconego alkoholu od CH3OH do C10H7-21OH oraz nasyconego, nienasyconego lub rozgałęzionego kwasu od HCOOH do C10H7-21COOH oraz środek powierzchniowo czynny w postaci rycynowego glicerolu makrogolu etoksylowanego od 30 do 50 cząsteczek tlenku etylenu. Przedmiotem zgłoszenia jest również lecznicza woda pitna, zawierająca tą kompozycję, zastosowanie kompozycji i wody oraz sposobu wytwarzania wody.
PL449854A 2024-09-18 2024-09-18 Kompozycja farmaceutyczna, lecznicza woda pitna, ich zastosowanie i sposób wytwarzania leczniczej wody pitnej PL449854A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL449854A PL449854A1 (pl) 2024-09-18 2024-09-18 Kompozycja farmaceutyczna, lecznicza woda pitna, ich zastosowanie i sposób wytwarzania leczniczej wody pitnej
PCT/PL2024/050078 WO2026063805A1 (en) 2024-09-18 2024-10-29 A pharmaceutical composition, medicated drinking water, their use and method of preparing medicated drinking water

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL449854A PL449854A1 (pl) 2024-09-18 2024-09-18 Kompozycja farmaceutyczna, lecznicza woda pitna, ich zastosowanie i sposób wytwarzania leczniczej wody pitnej

Publications (1)

Publication Number Publication Date
PL449854A1 true PL449854A1 (pl) 2026-03-23

Family

ID=93939496

Family Applications (1)

Application Number Title Priority Date Filing Date
PL449854A PL449854A1 (pl) 2024-09-18 2024-09-18 Kompozycja farmaceutyczna, lecznicza woda pitna, ich zastosowanie i sposób wytwarzania leczniczej wody pitnej

Country Status (2)

Country Link
PL (1) PL449854A1 (pl)
WO (1) WO2026063805A1 (pl)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130065846A1 (en) * 2011-09-12 2013-03-14 Mark D. Soll Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
EP3082867A1 (en) * 2013-12-20 2016-10-26 Intervet International B.V. Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals
WO2023037253A1 (en) * 2021-09-08 2023-03-16 Pi Industries Ltd Isoxazoline compounds and their use as pest control agents
WO2023221854A1 (zh) * 2022-05-20 2023-11-23 天津瑞普生物技术股份有限公司 一种抗寄生虫感染的口服药物制剂及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2874054T3 (es) * 2013-12-20 2021-11-04 Intervet Int Bv Uso de derivados de isoxazolina para el tratamiento o la prevención de la infestación con artrópodos en aves de corral
WO2018039508A1 (en) * 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130065846A1 (en) * 2011-09-12 2013-03-14 Mark D. Soll Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
EP3082867A1 (en) * 2013-12-20 2016-10-26 Intervet International B.V. Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals
WO2023037253A1 (en) * 2021-09-08 2023-03-16 Pi Industries Ltd Isoxazoline compounds and their use as pest control agents
WO2023221854A1 (zh) * 2022-05-20 2023-11-23 天津瑞普生物技术股份有限公司 一种抗寄生虫感染的口服药物制剂及其制备方法和应用

Also Published As

Publication number Publication date
WO2026063805A1 (en) 2026-03-26

Similar Documents

Publication Publication Date Title
US4657901A (en) Pharmaceutical composition
KR920021139A (ko) 약학 조성물
JP2015521995A5 (pl)
CA2525691A1 (en) A formulation for chemical peeling
CO5380014A1 (es) Formulacion farmaceuticas para la administracion oral o topica de compuestos hidrofobicos que no frma emulsion
NO20025629L (no) Formulering
CA2742645A1 (en) Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
RU2010139958A (ru) Стабилизированная фармацевтическая композиция, cодержащая доцетаксель
JPWO2005044276A1 (ja) プロスタグランジン含有医薬組成物
TWI716394B (zh) 外用醫藥組合物
JP3802105B2 (ja) ジクロフェナクナトリウム含有乳化外用剤
JP2015193634A (ja) 水性組成物
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
RU2011150246A (ru) Эмульсия "масло-в-воде" моментазона и пропиленгликоля
EP0440811B1 (en) Composition for percutaneous administration
PT1517682E (pt) Formulação farmacêutica compreendendo inibidor da renina não-peptídico e tensioactivo
KR950003611B1 (ko) 항진균 외용 이미다졸 제제
AU2016209917A1 (en) Galenic formulation comprising a topical drug
JP2019123755A (ja) 水性組成物
US20230000945A1 (en) Topical pharmaceutical formulations of a cyclic depsipeptide
JP5223307B2 (ja) 坐剤
JP2018534358A (ja) Ｖｅｇｆ阻害剤の局所投与による皮膚障害の処置
JP2008255113A (ja) 坐剤
RU2021136865A (ru) Лечение кожной формы красной волчанки
RU2024132897A (ru) Новый состав 2-(имидазол-4-ил)этанамида пентандиовой-1,5 кислоты